Bob Azelby – Juno Therapeutics

Bob Azelby

EVP, Chief Commercial Officer

Robert (“Bob”) Azelby is our Executive Vice President, Chief Commercial Officer and joined Juno in November 2015. Prior to joining Juno, Bob was the Vice President and General Manager of Amgen’s Oncology Business Unit. He was also the Vice President of Amgen’s U.S. Oncology Sales team, one of the largest oncology sales teams in the United States. In addition, Bob was the Vice President of Amgen’s North American Commercial Effectiveness Unit, responsible for sales and marketing functions, including market research, forecasting, sales training, and sales operations. Bob garnered international experience as Amgen’s General Manager, Netherlands, responsible for all aspects of its commercial operations in that country. Bob held numerous sales and marketing positions, each with increasing responsibilities. Roles included project management, business development, regional sales management, and national marketing director. Before joining Amgen, Bob was Chief Operating Officer for a venture-capital-backed early-stage company specializing in catastrophic event medical management. Bob also held the position of Chief Financial Officer for a subsidiary of Oxford Health Plans and was also a Professional Sales Representative for GlaxoWellcome. Bob received his undergraduate degrees in Economics and Religious Studies from the University of Virginia and his Master of Business Administration from Harvard University.